These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6710555)

  • 21. Interpretation of serum phenytoin concentrations in uremia is assay-dependent.
    Sirgo MA; Green PJ; Rocci ML; Vlasses PH
    Neurology; 1984 Sep; 34(9):1250-1. PubMed ID: 6540413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of three methods for predicting concentrations of free phenytoin.
    Beck DE; Farringer JA; Ravis WR; Robinson CA
    Clin Pharm; 1987 Nov; 6(11):888-94. PubMed ID: 3677566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ultrafiltrate volume on determination of free phenytoin concentration.
    McMillin GA; Juenke J; Dasgupta A
    Ther Drug Monit; 2005 Oct; 27(5):630-3. PubMed ID: 16175137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
    Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
    Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Beckman TL-100 ultracentrifuge with the Amicon Centrifree Micropartition filters to determine protein-free phenytoin concentrations.
    Zysset T; Hegel A
    Ther Drug Monit; 1987 Dec; 9(4):433-8. PubMed ID: 3424409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A micromethod for the estimation of free levels of anticonvulsant drugs in serum.
    Ratnaraj N; Goldberg VD; Hjelm M
    Clin Biochem; 1989 Dec; 22(6):443-50. PubMed ID: 2692873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia.
    Allison TB; Comstock TJ
    Ther Drug Monit; 1988; 10(4):376-81. PubMed ID: 3201522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of phenytoin protein binding in epileptic patients.
    DeMonaco HJ; Lawless LM
    Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase.
    Dasgupta A; Schlette E
    J Clin Lab Anal; 2001; 15(5):244-50. PubMed ID: 11574952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated determination of free phenytoin in human plasma with on-line equilibrium dialysis and column-switching high-performance liquid chromatography.
    Andresen AT; Rasmussen KE; Rugstad HE
    J Chromatogr; 1993 Nov; 621(2):189-98. PubMed ID: 8294541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micro-scale ultracentrifugation as an alternative to ultrafiltration for the determination of the unbound fraction of phenytoin in human serum.
    Jack L; Cunningham C; Watson ID; Stewart MJ
    Ann Clin Biochem; 1986 Sep; 23 ( Pt 5)():603-7. PubMed ID: 3532923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative determination of phenytoin in plasma by fluorescence polarization immunoassay and high performance liquid chromatography.
    Othman S; al-Turk WA; Awidi AS; Daradkeh TK; Shaheen O
    Drug Des Deliv; 1987 Sep; 2(1):41-7. PubMed ID: 3334544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: analysis of free drug fractions.
    Schiel JE; Tong Z; Sakulthaew C; Hage DS
    Anal Chem; 2011 Dec; 83(24):9384-90. PubMed ID: 22122161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue.
    Datta P; Scurlock D; Dasgupta A
    Ther Drug Monit; 2005 Jun; 27(3):305-8. PubMed ID: 15905800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abbott ARCHITECT iPhenytoin assay versus similar assays for measuring free phenytoin concentrations.
    Tacker DH; Robinson R; Perrotta PL
    Lab Med; 2014; 45(2):176-81. PubMed ID: 24869001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring phenytoin therapy using citric acid-stimulated saliva in infants and children.
    Lifshitz M; Ben-Zvi Z; Gorodischer R
    Ther Drug Monit; 1990 Jul; 12(4):334-8. PubMed ID: 2396306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Abbott TDx for the stat measurement of phenobarbital, phenytoin, carbamazepine, and theophylline.
    Loomis KF; Frye RM
    Am J Clin Pathol; 1983 Nov; 80(5):686-91. PubMed ID: 6637881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PETINIA total phenytoin assay on the vista 1500 analyzer is not suitable for monitoring free phenytoin concentration if ultrafiltration is performed at room temperature.
    Dasgupta A; Everett JM; Davis B
    Ther Drug Monit; 2013 Jun; 35(3):384-7. PubMed ID: 23666578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric toxicity of phenytoin. Importance of monitoring phenytoin levels.
    Phelps SJ; Baldree LA; Boucher BA; Hogue SL
    Clin Pediatr (Phila); 1993 Feb; 32(2):107-10. PubMed ID: 8432072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.